Individualized Strength Training: Programs tailored to your medical history and any musculoskeletal conditions identified during evaluation
However, if your child has concurrent diabetes, your insurance may cover a formulation that is approved for diabetes management
Activation of the glucagon-like peptide 1 (GLP-1) receptor has been shown to decrease glucose, reduce appetite, lower body weight, and improve insulin sensitivity in patients with type 2 diabetes, obesity, or both
Gastroenterology 146(1289300):e1-19
Safety and eligibility Your provider reviews contraindications, medication interactions, goals, and safety factors before prescribing
Pfizers efforts to secure exclusive rights to emerging GLP-1 modalities, including an oral GLP-1 candidate in early-stage development with Shanghai Fosuns YaoPharma, reflected a broader industry push to diversify delivery formats and expand market reach